Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin

Neoadjuvant chemotherapy (NCT) is one of the main treatment strategies for patients with locally advanced breast cancer. In this study, we focused on the predictive and prognostic value of Ki-67 in triple-negative breast cancer (TNBC) patients who received NCT. Data from 280 patients with stage II–I...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruo-Xi, Chen, Sheng, Jin, Xi, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948023/
https://www.ncbi.nlm.nih.gov/pubmed/27426056
http://dx.doi.org/10.1038/srep30091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948023/
https://www.ncbi.nlm.nih.gov/pubmed/27426056
http://dx.doi.org/10.1038/srep30091

Ejemplares similares